We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us

Download Mobile App


ATTENTION: Due to the COVID-19 PANDEMIC, many events are being rescheduled for a later date, converted into virtual venues, or altogether cancelled. Please check with the event organizer or website prior to planning for any forthcoming event.

New Method for Detection of Breast Arterial Calcifications via Mammograms Indicates Likelihood of Heart Disease

By MedImaging International staff writers
Posted on 16 Feb 2022
Print article
Image: Quantifying BACs to assess heart disease risk (Photo courtesy of Volpara Health)
Image: Quantifying BACs to assess heart disease risk (Photo courtesy of Volpara Health)

A new method for the detection and quantification of breast arterial calcifications (BACs) has important implications for heart disease risk.

Volpara Health (Wellington, New Zealand) has secured a US patent focused on detection of (BACs) via mammograms. BACs are medial calcifications of the mammary arteries (inappropriate and pathological depositions of mineral in the form of calcium phosphate salts). Generally considered as a benign and incidental finding from an oncological perspective, BACs have been demonstrated to be associated with chronic kidney disease, bone mineral density reduction, diabetes mellitus, metabolic syndrome, hypertension, coronary artery disease, and strokes.

Most clinical research correlating BACs with the risk of coronary artery disease has relied on the absence versus presence of BACs, or semi-quantitative BAC metrics with large uncertainty and standard deviation. Consequently, there have been inconsistent findings. That was exactly the same situation as with breast density measurement until researchers made the field much more quantitative and objective by using more automated algorithms. While a commercial software product that can detect and quantify BACs during routine mammographic screening, using this data then predict a patient's risk of heart disease will require further development.

This latest patent - which builds off Volpara Health's approach to quantitative and objective breast density scoring -is a significant advance. Using breast tissue composition and anthropomorphic measures, a tissue composition map that identifies BACs can be created from a mammogram. Subsequently, a score is generated that indicates the likelihood of heart disease resulting from these calcifications.

"This patent is an important advancement in patient care. Being able to quantify breast arterial calcifications has the potential to take what are often considered incidental, insignificant findings on a mammogram, and triage patients to cardiac care and interventions," said Volpara CEO Ralph Highnam.

Related Links:
Volpara Health 

Print article
Sun Nuclear -    Mirion



view channel
Image: The FDA has cleared the CSA system with Dynamic Digital Radiography (Photo courtesy of 20/20 Imaging)

Advanced Digital X-Ray System Allows Clinicians to Capture and Visualize Anatomy in Motion

Dynamic Digital Radiography (DDR) is a revolutionary X-ray technology that enables the visualization of anatomy in motion, so clinicians can interpret the dynamic interaction of anatomical structures,... Read more


view channel
Image: EG-740UT ultrasound endoscope combined with ARIETTA 850 provides outstanding ultrasound image quality (Photo courtesy of FUJIFILM)

Next-Gen Ultrasound Endoscope Enables Complex Diagnostic and Therapeutic Procedures

Endoscopic ultrasound is a specialist procedure performed utilizing an endoscope equipped with an ultrasonic transducer which emits and receives ultrasonic waves within the gastrointestinal tract, such... Read more

Imaging IT

view channel

Global AI in Medical Diagnostics Market to Be Driven by Demand for Image Recognition in Radiology

The global artificial intelligence (AI) in medical diagnostics market is expanding with early disease detection being one of its key applications and image recognition becoming a compelling consumer proposition... Read more
Copyright © 2000-2022 Globetech Media. All rights reserved.